Liberal Use of Sodium in Ambulatory Heart Failure
NCT04226755 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2023-06-22
Summary
This study investigates the effects of an increased sodium intake in heart failure patients with reduced ejection fraction and age-matched volunteers without heart failure.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Sodium chloride
1 gram tid (with every meal)
Sponsors & Collaborators
-
Ziekenhuis Oost-Limburg
lead OTHER
Principal Investigators
-
Jeroen Dauw, MD · Ziekenhuis Oost-Limburg
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-06-01
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- Belgium
Study Locations
More Related Trials
-
Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction
NCT02262078 ·Status: COMPLETED ·Phase: PHASE2
-
0.5M Na Lactate Solution in Acute Heart Failure (AHF)
NCT01981655 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
NCT00043758 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
NCT00391846 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF)
NCT00699712 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure
NCT00160134 ·Status: COMPLETED ·Phase: PHASE2
-
NT-proBNP Measurements to Rule-out Heart Failure Among Patients With Atrial Fibrillation: A Prospective Clinical Study
NCT04125966 ·Status: UNKNOWN
-
Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure
NCT00132886 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure
NCT01055912 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Ketones and Niacin in Heart Failure Patients
NCT04703361 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Dietary Nitrate Supplementation on Cardiorespiratory Control in Chronic Heart Failure
NCT02401126 ·Status: COMPLETED ·Phase: PHASE4
-
Exogenous Ketones for Acutely Decompensated HEart Failure
NCT04698005 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients
NCT00043771 ·Status: COMPLETED ·Phase: PHASE2
-
Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF
NCT00693745 ·Status: COMPLETED
-
Impact of a Novel Heart Failure Medication Decision Aid
NCT06247371 ·Status: COMPLETED ·Phase: NA
-
Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure
NCT04107220 ·Status: UNKNOWN ·Phase: NA
-
Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure
NCT05652322 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Ketones in Heart Failure - Effects on Cardiac Efficiency
NCT03073356 ·Status: COMPLETED ·Phase: PHASE2
-
Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)
NCT00729222 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients
NCT06092437 ·Status: RECRUITING ·Phase: NA
-
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
NCT01035255 ·Status: TERMINATED ·Phase: PHASE3
-
Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
NCT01644331 ·Status: COMPLETED ·Phase: PHASE3
-
Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension
NCT06405555 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels
NCT00271557 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
NCT07218627 ·Status: RECRUITING ·Phase: PHASE1